This data is used for research, to audit care, to help plan breast cancer services, and to identify where further progress is needed to improve the lives of everyone affected by breast cancer, now and in the future.
- Te Rēhita Mate Ūtaetae, the Breast Cancer Foundation National Register, holds a rich database of over 38,000 patients who have been diagnosed with invasive and pre-invasive breast cancer between 2000 and 2021. Approximately 4,000 new patient registrations are added each year.
- Data on Te Rēhita, the National Register, has been collected since 2000 for use in research and audit to help improve diagnosis, treatment and outcomes.
- From 1 January 2020, Te Rēhita, the National Register, includes all patients diagnosed with pre-invasive and invasive breast cancer in New Zealand from Northland to Southland.
- Of the patients in these regions, more than 99% are included in Te Rēhita, the National Register (less than 1% opt out).
- New Zealand is a world leader in the collection of near-national data about advanced breast cancer (ABC) diagnosis and treatment. Source: BCFNZ Study into metastatic / advanced breast cancer.
Te Rēhita, the National Register, collects information on
- Faster cancer treatment
- Risk and additional factors
- Advanced breast cancer
Based on Te Rēhita, the National Register, data analysed in 2012:
- The majority of breast cancer patients (64%) are aged between 45 and 69 years old.
- 76% of breast cancer patients are NZ European, 9% are NZ Māori, 7% are Asian and 5% are Pasifika.
Every two years, Te Rēhita, the National Register, report will highlight key statistics and trends and investigate select questions from NZ clinicians and the public.
To read published reports generated from Te Rēhita, the National Register, data, click below.
Data from Te Rēhita, the National Register, is used for:
- Epidemiology and changing patterns of breast cancer
- Assessing efficacy and treatment of existing and new treatments
- Identifying regional and NZ-specific cancer trends
- Assessing and addressing inequities in care
- Indirectly enabling other research, e.g. clinical context for cancer genome research
- Healthcare planning
- Audits for quality measurement and improvement, e.g. BreastSurgANZ Quality Audit
Data from breast cancer patients in both public and private healthcare systems is collected from hospitals and health professionals by authorised data managers.
The more complete the data, the greater the value of Te Rēhita, the National Register, for improving treatment and care in the future. Therefore, patients are followed up all their lives. If needed, general practitioners (GPs) may also be contacted by an authorised data manager for annual follow-up data, including breast cancer medications prescribed and any recurrent or new breast cancers.
Te Rēhita, the National Register, is an opt-out database. If you do not want to be included please click here.
Te Rēhita Mate Ūtaetae, the Breast Cancer Foundation National Register, operates in compliance with our ethics approval 16/NTA/139/AM03, The Privacy Act 1993, the Health Information Privacy Code and the principles of the Treaty of Waitangi.
Ethics approval is provided by the Health and Disability Ethics Committee (HDEC). The Health and Disability Ethics Committee (HDEC) is a Ministerial committee (established under section 11 of the New Zealand Public Health and Disability Act), whose function is to secure the benefits of health and disability research by checking that it meets or exceeds established ethical standards. For more information, visit the Health and Disability Ethics Committee website.
All data requests are reviewed for ethics approval before release. Only de-identified data is released. For more information see Data Request.